Inventor · disambiguated record
Ting-Long Lin
Also filed as: LIN TING-LONG
6 granted patents·5 pending applications·22 citations·filing 2017–2023
82Inventor score
Files withIMUNAMI LABORATORIES PTE LTD11
Top patents by PatentIndex Score
11 records- 0193US10150801B1Recombinant polypeptides and methods of use thereofIMUNAMI LABORATORIES PTE LTD·Filed 2017·Granted Dec 11, 2018·7 cites·3 claims
- 0291US10351607B1Recombinant polypeptides and methods of use thereofIMUNAMI LABORATORIES PTE LTD·Filed 2018·Granted Jul 16, 2019·3 cites·2 claims
- 0389US10323071B1Recombinant polypeptides and methods of use thereofIMUNAMI LABORATORIES PTE LTD·Filed 2018·Granted Jun 18, 2019·3 cites·4 claims
- 0485US10301364B1Recombinant polypeptides and methods of use thereofIMUNAMI LABORATORIES PTE LTD·Filed 2018·Granted May 28, 2019·3 cites·12 claims
- 0585US2024010692A1Recombinant polypeptides and methods of use thereofIMUNAMI LABORATORIES PTE LTD·Filed 2023·Application pending·0 cites
- 0682US10675332B1Recombinant polypeptides and methods of use thereofIMUNAMI LABORATORIES PTE LTD·Filed 2019·Granted Jun 9, 2020·4 cites·28 claims
- 0782US10370421B2Recombinant polypeptides and methods of use thereofIMUNAMI LABORATORIES PTE LTD·Filed 2018·Granted Aug 6, 2019·2 cites·18 claims
- 0874US2021147494A1Recombinant polypeptides and methods of use thereofIMUNAMI LABORATORIES PTE LTD·Filed 2021·Application pending·0 cites
- 0970US2019315818A1Recombinant polypeptides and methods of use thereofIMUNAMI LABORATORIES PTE LTD·Filed 2019·Application pending·0 cites
- 1050US2024293504A1Recombinant polypeptides and combinations for use in the treatment of cancerIMUNAMI LABORATORIES PTE LTD·Filed 2020·Application pending·0 cites
- 1150US2021393741A1Recombinant polypeptides and methods for use in the treatment of cancerIMUNAMI LABORATORIES PTE LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ting-Long Lin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →